Announcements Trials
Browse Landscape

Status

Completed 14Recruiting 4Unknown 3Terminated 2Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1NET 1Endocrine 1

Conditions

Neoplasms 7Neuroblastoma 4Recurrence 3Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Insulinoma 2Immunologic Deficiency Syndromes 2Hypoglycemia 2Hyperinsulinism 2Hematologic Neoplasms 2Typical Teratoid Rhabdoid Tumor 1Triple Negative Local Advanced Breast Cancer 1Thyroid Nodule 1Thalassemia 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oncology Patients With Gastroparesis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Medulloblastoma 1Lymphoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × Fibrosarcoma × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡